Tag Archives: generics

Spanish Generics Industry to Government: "Leave Branded Pharma Alone"

Just days before the reports that R&D investment in Spanish pharma had fallen to below EUR1 billion ($1.3 billion) in 2011 for the first time since 2007, the country’s generic manufacturers association, AESEG, offered some unexpected support for the branded industry. In comments to APM Health Europe described as “rare”, AESEG chief Ángel Luis Rodríguez […]
Posted in Europe, Global, healthcare | Also tagged , , , , , | Leave a comment

Drug Reimbursement and the "New Medicaid"

by Tom Norton A lot has been written about the “state option” created by the Supreme Court ruling on HCR, and what it means to American medicine. Sorting out an opinion will, to a degree, depend on whom you read and what you believe. But regardless of where you come out on this issue, there […]
Posted in Guest Blog, healthcare, Legal, Market Access, R&D, Regulatory | Also tagged , , , , , , , | 1 Comment

Supreme Court Considers the Affordable Care Act

Posted in Corporate Responsibility, healthcare, Legal, Regulatory, Strategy | Also tagged , , , , , , , | Leave a comment

AZ's Seroquel Battle with FDA: A Mark of Desperation?

By Ana Nicholls, Healthcare Analyst at the Economist Intelligence Unit. Is it a mark of desperation? UK-based pharma company AstraZeneca has resorted to suing the US Food and Drug Administration in a bid to stop it from approving generic competition to Seroquel, the company’s blockbuster anti-depressant, before December 2012. The core patent for Seroquel IR expired in […]
Posted in Guest Blog | Also tagged , , | 3 Comments

Obama Deficit Plan Sides With PBMs Over Big Pharma

Amid the flurry of cost-cutting proposals aimed at guiding the Joint Select Committee on Deficit Reduction’s (Super Committee) budgetary blade, the Obama Administration has now weighed in with a proposal to cut $248 billion from Medicare spending over ten years, and $73 billion in Medicaid and other health-related spending. The Obama plan, which would increase […]
Posted in healthcare, leadership, Regulatory, Strategy | Also tagged , , , , | Leave a comment
  • Categories

  • Meta